H-1B sponsorship profile: New Mexico Oncology Hematology Consultants, Ltd (New Mexico Cancer Center). Across U.S. Department of Labor LCA disclosures, New Mexico Oncology Hematology Consultants, Ltd (New Mexico Cancer Center) filed 2 Labor Condition Applications covering 2 H-1B worker positions between fiscal year 2023 and fiscal year 2023. The employer’s DOL certification rate sits at 100% (2 certified of 2 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on New Mexico Oncology Hematology Consultants, Ltd (New Mexico Cancer Center)’s H-1B petitions range from $278,283 at the low end to $378,934 at the high end, with a petition-weighted average of $328,609. That range reflects the mix of occupations the company sponsors, led by Medical Oncologist (2 petitions at $328,609 avg). H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. New Mexico Oncology Hematology Consultants, Ltd (New Mexico Cancer Center) is headquartered in Albuquerque, NM under NAICS code 621111, and places H-1B workers across 1 state, most heavily in NM. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where New Mexico Oncology Hematology Consultants, Ltd (New Mexico Cancer Center) ranks. By H-1B petition volume, New Mexico Oncology Hematology Consultants, Ltd (New Mexico Cancer Center) is #48,558 of 119,880 employers nationally and #130 of 382 employers headquartered in NM. Both ranks are computed live from the same underlying petition counts, not a separate estimate.